Rallybio (RLYB) Metrics: History & Chart

Rallybio Corporation(RLYB)

Biotechnology · New Haven, CT

$17.08+0.18 (+1.07%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Rallybio Corporation

Rallybio Corporation is a clinical-stage biotechnology firm dedicated to discovering and bringing to market transformative therapies for individuals facing severe and uncommon illnesses. Its most advanced therapeutic candidate, RLYB212, is a monoclonal anti-HPA-1a antibody currently undergoing Phase II clinical trials. This candidate, along with RLYB211, is aimed at preventing fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company's pipeline also includes RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for addressing ophthalmic conditions driven by complement system activity. Furthermore, RLYB116, an inhibitor designed to target complement component 5 (C5) for various complement dysregulation disorders, has successfully completed its Phase 1 trial. Another preclinical antibody, RLYB332, is under investigation for treating severe anemia characterized by ineffective erythropoiesis and iron overload. Rallybio has established strategic collaborations to further its development efforts. It maintains an alliance with AbCellera for the identification, development, and commercialization of novel antibody-based therapeutics in rare diseases. Additionally, the firm partners with Exscientia on the creation of small molecule therapeutics for rare diseases, and with Johnson & Johnson to deliver therapeutic options to expectant mothers at risk of fetal and neonatal alloimmune thrombocytopenia. Established in 2018, Rallybio Corporation is headquartered in New Haven, Connecticut.

New Haven, CT

7 employees

www.rallybio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Stephen Uden

View full financials

Third-Party DCF Estimate (FMP)	$9.76
Price Gap vs Third-Party Estimate	-42.78%

7D Total Return	-0.88%
30D Total Return	-0.18%
YTD Total Return	+207.83%
1Y Total Return	+273.89%
3Y Total Return	-43.67%
5Y Total Return	-89.09%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+207.83%
2025	-28.52%
2024	-59.83%
2023	-63.62%
2022	-31.13%
2021	N/A
2020

CAGR TTM	+271.55%
CAGR 3Y	-17.41%
CAGR 5Y	-35.80%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	2.17
PE Ratio Avg TTM	2.16
PE Ratio Avg 3Y	2.16
Current VS TTM Avg	+0.26%
Current VS 3Y Avg	+0.26%
Current VS 5Y Avg	+0.26%

All Metrics

RLYB Valuation Metrics

RLYB Stock Price Metrics

RLYB Dividend Metrics

RLYB Growth Rate Metrics

RLYB Discounted Cash Flow Metrics

RLYB Returns By Period

RLYB Yearly Returns

RLYB Average Annual Returns By Period (CAGR)

RLYB Revenue Metrics

RLYB PE Ratio Metrics

RLYB PS Ratio Metrics

RLYB PB Ratio Metrics

RLYB Price to Free Cash Flow Ratio Metrics

RLYB Debt to Equity Ratio Metrics

RLYB PEG Ratio Metrics

RLYB FCF Yield

RLYB Earnings Yield

RLYB EBITDA Yield

RLYB OCF Yield

RLYB EV/EBIT Ratio Metrics

RLYB EV/EBITDA Ratio Metrics

RLYB EV/Assets Ratio Metrics

RLYB EV/Sales Ratio Metrics

RLYB Current Ratio Metrics

RLYB Quick Ratio Metrics

RLYB ROIC Metrics

RLYB Return on Assets Metrics

RLYB Return on Equity Metrics

RLYB Net Profit Margin Metrics

RLYB Gross Profit Margin Metrics

RLYB Tax Rate Metrics

PS Ratio	151.68
PS Ratio Avg TTM	79.38
PS Ratio Avg 3Y	73.69
Current VS TTM Avg	+91.08%
Current VS 3Y Avg	+105.82%
Current VS 5Y Avg	+105.82%

PB Ratio	1.04
PB Ratio Avg TTM	0.97
PB Ratio Avg 3Y	0.62
Current VS TTM Avg	+7.49%
Current VS 3Y Avg	+68.84%
Current VS 5Y Avg	-3.17%

PFCF Ratio	3.72
PFCF Ratio Avg TTM	3.72
PFCF Ratio Avg 3Y	3.72
Current VS TTM Avg	+0.12%
Current VS 3Y Avg	+0.12%
Current VS 5Y Avg	+0.12%

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	26.88%
FCF Yield Avg TTM	26.92%
FCF Yield Avg 3Y	26.92%
Current VS TTM Avg	-0.15%
Current VS 3Y Avg	-0.15%
Current VS 5Y Avg	-0.15%

Earnings Yield	46.15%
Earnings Yield Avg TTM	46.22%
Earnings Yield Avg 3Y	46.22%
Current VS TTM Avg	-0.15%
Current VS 3Y Avg	-0.15%
Current VS 5Y Avg	-0.15%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.05
Ev/Assets Ratio Avg TTM	0.41
Ev/Assets Ratio Avg 3Y	0.31
Current VS TTM Avg	-87.81%
Current VS 3Y Avg	-83.84%
Current VS 5Y Avg	-91.95%

Ev/Sales Ratio	7.95
Ev/Sales Ratio Avg TTM	28.63
Ev/Sales Ratio Avg 3Y	35.39
Current VS TTM Avg	-72.23%
Current VS 3Y Avg	-77.54%
Current VS 5Y Avg	-77.54%

Current Ratio	27.26
Current Ratio Avg TTM	15.88
Current Ratio Avg 3Y	12.44
Current VS TTM Avg	+71.67%
Current VS 3Y Avg	+119.23%
Current VS 5Y Avg	+63.84%

Quick Ratio	27.26
Quick Ratio Avg TTM	15.88
Quick Ratio Avg 3Y	12.44
Current VS TTM Avg	+71.67%
Current VS 3Y Avg	+119.23%
Current VS 5Y Avg	+63.84%

ROIC	(24.40%)
ROIC Avg 3Y	(73.57%)
ROIC Avg 5Y	(59.08%)
Current VS 3Y Avg	+66.84%
Current VS 5Y Avg	+58.71%
Current VS 10Y Avg	+56.40%

ROA	46.45%
ROA Avg TTM	4.92%
ROA Avg 3Y	(15.57%)
Current VS TTM Avg	+844.95%
Current VS 3Y Avg	+398.33%
Current VS 5Y Avg	+460.36%

ROE	48.20%
ROE Avg TTM	(19.19%)
ROE Avg 3Y	(56.09%)
Current VS TTM Avg	+351.22%
Current VS 3Y Avg	+185.94%
Current VS 5Y Avg	+199.65%

Net Profit Margin	7051.24%
Net Profit Margin Avg TTM	(712.58%)
Net Profit Margin Avg 3Y	(2257.72%)
Current VS TTM Avg	+1089.53%
Current VS 3Y Avg	+412.32%
Current VS 5Y Avg	+639.46%

Gross Profit Margin	89.28%
Gross Pft Margin Avg TTM	(1213.43%)
Gross Pft Margin Avg 3Y	(862.60%)
Current VS TTM Avg	+107.36%
Current VS 3Y Avg	+110.35%
Current VS 5Y Avg	N/A

Tax Rate	2.94%
Tax Rate Avg 3Y	1.47%
Tax Rate Avg 5Y	1.47%
Current VS 3Y Avg	+100.00%
Current VS 5Y Avg	+100.00%
Current VS 10Y Avg	+100.00%